Skip to content

INtra-operative evaluation of a novel FLUorescENt C-mEt tracer in penile and tongue cancer - INFLUENCE

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518046-25-00
Enrollment
20
Registered
2024-11-12
Start date
2019-12-17
Completion date
Unknown
Last updated
2024-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

penile carcinoma, tongue carcinoma

Brief summary

The feasibility of intraoperative tumour visualization by means of c-MET targeted fluores-cence imaging will be evaluated, and the imaging result will be correlated to the level of c-MET expression determined using standard immunohistochemistry.

Detailed description

Detection and visualization of lymph node metastases in penile and tongue tumour patients., Identification of dysplasia or carcinoma in situ in penile and tongue tumours.

Interventions

Sponsors

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The feasibility of intraoperative tumour visualization by means of c-MET targeted fluores-cence imaging will be evaluated, and the imaging result will be correlated to the level of c-MET expression determined using standard immunohistochemistry.

Secondary

MeasureTime frame
Detection and visualization of lymph node metastases in penile and tongue tumour patients., Identification of dysplasia or carcinoma in situ in penile and tongue tumours.

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026